logo

ONCT(Delisted)

OncternalยทNASDAQ
--
--(--)

ONCT Profile

Oncternal Therapeutics, Inc.

A biopharmaceutical company that developing therapeutics for cancers

--
09/24/1997
02/03/2004
NASDAQ Stock Exchange
27
12-31
Common stock
12230 El Camino Real, Suite 300, San Diego, CA 92130
--
Oncternal Therapeutics, Inc., a Delaware corporation, was incorporated on September 24, 1997. The Company is a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies for the treatment of cancer patients with critical unmet medical needs. Oncternal pursues drug development, targeting promising but untapped biological pathways related to cancer generation or progression, with a focus on prostate cancer and hematological malignancies.